Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis

被引:99
|
作者
Baskol, Gulden [1 ]
Baskol, Mevlut
Kocer, Derya
机构
[1] Erciyes Univ, Fac Med, Dept Biochem & Clin Biochem, Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Gastroenterol, Kayseri, Turkey
关键词
non-alcoholic steatohepatitis; superoxide dismutase; nitric oxide; paraoxonase;
D O I
10.1016/j.clinbiochem.2007.02.006
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Oxidative stress is an important pathophysiological mechanism in non-alcoholic steatohepatitis (NASH). We aimed to evaluate serum xanthine oxidase (XO) (as a generator of reactive oxygen species), superoxide dismutase (SOD), glutathione peroxidase (GSHPx), paraoxonase (PON1) activities, nitric oxide (NO) and thiol levels in patients with NASH. Design and methods: A total of 35 patients with NASH and 31 age-and-gender-matched healthy subjects were enrolled in the study as control group. Serum levels of XO, NO, SOD, GSHPx, PON1 and thiol were determined by spectrophotometric methods. Results: Serum XO activities were higher in the patients with NASH than the controls (p < 0.001). Serum NO levels, SOD, GSHPx, PON1 activities and thiol levels were lower in the patients with NASH than the controls (p < 0.031, p < 0.019, p < 0.001, p < 0.001, p < 0.001, respectively). Conclusions: Increased oxidative stress in patients with NASH may result in a pro-oxidation environment, which in turn could result in decreased antioxidant enzyme activities and NO levels. Therefore effective antioxidant therapy to inhibit oxidative stress is necessary and agents to increase antioxidant enzyme may be a therapeutic option in NASH. (c) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:776 / 780
页数:5
相关论文
共 50 条
  • [21] Clinical significance of serum ornithine carbamoyltransferase in patients with non-alcoholic steatohepatitis
    Tokushige, Katsutoshi
    Hashimoto, Etsuko
    Noto, Haruka
    Yatsuji, Satoru
    Tobari, Maki
    Torii, Nobuyuki
    Taniai, Makiko
    Shiratori, Keiko
    Murayama, Hiroshi
    HEPATOLOGY RESEARCH, 2009, 39 (09) : 939 - 943
  • [22] Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients
    Tiniakos, D. G.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (10-11): : 930 - 939
  • [23] Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis
    Loffredo, L.
    Del Ben, M.
    Perri, L.
    Carnevale, R.
    Nocella, C.
    Catasca, E.
    Baratta, F.
    Ceci, F.
    Polimeni, L.
    Gozzo, P.
    Violi, F.
    Angelico, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (03) : 279 - 286
  • [24] Oxidative stress biomarkers among Saudi patients with non-alcoholic steatohepatitis versus chronic hepatitis C
    Al-Jiffri, Osama H.
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2016, 13 (04): : 81 - 85
  • [25] Monitoring oxidative stress in patients with non-alcoholic and alcoholic liver diseases
    Das S.K.
    Vasudevan D.M.
    Indian Journal of Clinical Biochemistry, 2005, 20 (2) : 24 - 28
  • [26] Non-alcoholic steatohepatitis
    Dancygier, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (33) : 930 - 930
  • [27] Non-Alcoholic Steatohepatitis
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (20): : 61 - 61
  • [28] Non-alcoholic steatohepatitis
    Romero-Gomez, Manuel
    MEDICINA CLINICA, 2022, 159 (08): : 388 - 395
  • [29] Non-alcoholic steatohepatitis
    Caballería, J
    Rodés, J
    MEDICINA CLINICA, 2003, 120 (17): : 670 - 675
  • [30] Non-alcoholic steatohepatitis
    Saibara, T
    Onishi, S
    Ogawa, T
    Yoshida, S
    Enzan, H
    LANCET, 1999, 354 (9186): : 1299 - 1300